EBAC
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
EBAC
Delisted
EBAC was delisted on the 2nd of March, 2023.
46 hedge funds and large institutions have $66.8M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Millennium Management
New York
|
+$4.66M |
2 |
Bank of America
Charlotte,
North Carolina
|
+$2.53M |
3 |
GCL
Glazer Capital LLC
New York
|
+$1.78M |
4 |
SC
Sculptor Capital
New York
|
+$1.58M |
5 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$1.46M |
Top Sellers
1 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$1.93M |
2 |
D.E. Shaw & Co
New York
|
-$1.32M |
3 |
CCM
CAAS Capital Management
New York
|
-$937K |
4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$383K |
5 |
AMH
Apollo Management Holdings
New York
|
-$63.4K |